A controlled trial of pimozide and trifluoperazine in chronic schizophrenic syndromes.
D000328:Adult; D000368:Aged; D001835:Body Weight / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D003864:Depression, Chemical; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010259:Paranoid Disorders / Q000097:blood / Q000188:drug therapy*; D010868:Pimozide / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D014268:Trifluoperazine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D010868:Pimozide; D014268:Trifluoperazine